Gene · 406953
Papers4,478
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 4,478
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Downstream Targets of VHL/HIF-α Signaling in Renal Clear Cell Carcinoma Progression: Mechanisms and Therapeutic Relevance. | Cancers (Basel) | 2023 | 36831657 | PubTator, text mining | PubMed |
| Noncoding RNAs Controlling Oxidative Stress in Cancer. | Cancers (Basel) | 2023 | 36831498 | PubTator, text mining | PubMed |
| Potential miRNA Use as a Biomarker: From Breast Cancer Diagnosis to Metastasis. | Cells | 2023 | 36831192 | PubTator, text mining | PubMed |
| Regulation of the Epithelial to Mesenchymal Transition in Osteosarcoma. | Biomolecules | 2023 | 36830767 | PubTator, text mining | PubMed |
| miRNA-Induced Downregulation of IPMK in Macrophages Mediates Lipopolysaccharide-Triggered TLR4 Signaling. | Biomolecules | 2023 | 36830701 | PubTator, text mining | PubMed |
| Nuclear PTEN's Functions in Suppressing Tumorigenesis: Implications for Rare Cancers. | Biomolecules | 2023 | 36830628 | PubTator, text mining | PubMed |
| Identification of Driver Genes and miRNAs in Ovarian Cancer through an Integrated In-Silico Approach. | Biology (Basel) | 2023 | 36829472 | PubTator, text mining | PubMed |
| Combining non-negative matrix factorization with graph Laplacian regularization for predicting drug-miRNA associations based on multi-source information fusion. | Front Pharmacol | 2023 | 36817132 | PubTator, text mining | PubMed |
| Breast cancer tumor microenvironment affects Treg/IL-17-producing Treg/Th17 cell axis: Molecular and therapeutic perspectives. | Mol Ther Oncolytics | 2023 | 36816749 | PubTator, text mining | PubMed |
| LncRNA CASC2 Regulate Cell Proliferation and Invasion by Targeting miR-155/SOCS1 Axis in Hepatocellular Carcinoma. | J Oncol | 2023 | 36816357 | PubTator, text mining | PubMed |
| METTL14-dependent maturation of pri-miR-17 regulates mitochondrial homeostasis and induces chemoresistance in colorectal cancer. | Cell Death Dis | 2023 | 36810285 | PubTator, text mining | PubMed |
| A Comprehensive Study on the Anti-cancer Effects of Quercetin and Its Epigenetic Modifications in Arresting Progression of Colon Cancer Cell Proliferation. | Arch Immunol Ther Exp (Warsz) | 2023 | 36807774 | PubTator, text mining | PubMed |
| Modulating epigenetic modifications for cancer therapy (Review). | Oncol Rep | 2023 | 36799181 | PubTator, text mining | PubMed |
| Recent advances of small extracellular vesicle biomarkers in breast cancer diagnosis and prognosis. | Mol Cancer | 2023 | 36797736 | PubTator, text mining | PubMed |
| Epigenetic regulation in hematopoiesis and its implications in the targeted therapy of hematologic malignancies. | Signal Transduct Target Ther | 2023 | 36797244 | PubTator, text mining | PubMed |
| MicroRNA signature and integrative omics analyses define prognostic clusters and key pathways driving prognosis in patients with neuroendocrine neoplasms. | Mol Oncol | 2023 | 36795001 | PubTator, text mining | PubMed |
| Systematic analysis of the BET family in adrenocortical carcinoma: The expression, prognosis, gene regulation network, and regulation targets. | Front Endocrinol (Lausanne) | 2023 | 36793283 | PubTator, text mining | PubMed |
| MED27 plays a tumor-promoting role in breast cancer progression by targeting KLF4. | Cancer Sci | 2023 | 36786527 | PubTator, text mining | PubMed |
| Circ_0000566 contributes oxygen-glucose deprivation and reoxygenation (OGD/R)-induced human brain microvascular endothelial cell injury via regulating miR-18a-5p/ACVR2B axis. | Metab Brain Dis | 2023 | 36781583 | PubTator, text mining | PubMed |
| Male- and female-specific microRNA expression patterns in a mouse model of methanol poisoning. | Food Chem Toxicol | 2023 | 36780935 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406953/papers?page=20